Surgical Robotics Technology
Surgical Robotics Technology is proud to announce the winners of the Surgical Robotics Industry Awards 2025, recognising the exceptional contribution of individuals, organisations and technologies in the industry.
The 2025 Awards are in five categories: Industry Leadership, Innovative Start-up, Outstanding Company, Outstanding Healthcare Provider, and Groundbreaking Technology.
Winner announcement video and details are shown below.
Category: Industry Leadership
Winner: Prof. Dr. Alex Mottrie – CEO of Orsi Academy
Prof. Dr. Alex Mottrie is a renowned urologist and CEO of Orsi Academy, Europe’s largest robotic surgery training center. Since 2002, Prof. Mottrie has performed over 6,000 robotic procedures, developing key techniques adopted globally. Under his leadership, Orsi Academy has become one of Europe’s largest robotic surgery training centers, collaborating with top universities like Ghent and Leuven. Through Orsi Innotech, a lot of basic work is done in Surgical AI. He received several lifetime achievement awards, amongst the EAU Innovators in Urology Awards 2025, EAU25 Madrid.
“I feel extremely humbled and proud to receive the 2025 Surgical Robotics Industry Awards. This is an award that puts the whole team of Orsi Academy, Orsi Innotech and the Urological Department of the Azorg Hospital Aalst rightfully in the spotlight.
These teams are striving for excellence and always seek to innovate in order to improve Healthcare. We want to achieve our mission by innovating and standardizing surgical training but also making surgery safer through Surgical AI based software.
Orsi Academy aims to become a comprehensive platform where Academy, Industry and Clinicians meet to jointly advance in this innovative field.”
Prof. Dr. Alex Mottrie, CEO of Orsi Academy
Category: Innovative Start-up
Winner: ForSight Robotics
ForSight Robotics is transforming global healthcare through technological innovation. Utilizing advanced computer visualization, AI-based algorithms, and microsurgical robotics, the company seeks to empower ophthalmic surgeons and improve patients’ lives. ForSight Robotics aims to democratize quality surgical ophthalmic care and bring hope to millions of patients by restoring sight, worldwide.
“We are honored to be recognized for our innovation in surgical robotics. This award is a testament to our team’s dedication and commitment to transforming surgical eye care and to ensuring that patients everywhere have access to the most precise, high-quality, sight-saving treatment. As we continue to push technological boundaries and advance the development of our ORYOM Platform, we are driven by our mission to democratize access to top-tier surgical eye care for patients worldwide.”
Dr. Joseph Nathan, ForSight Robotics’ Co-founder, President, and Chief Medical Officer.
Category: Outstanding Company
Winner: Medtronic
Medtronic is a global healthcare technology leader. The company’s 1Hugo™ robotic-assisted surgery (RAS) system is in use in hospitals for urologic, gynecologic, and general surgery procedures. In addition, its Touch Surgery™ Enterprise enables surgeons to securely access their case footage seconds after the procedure is complete. The company’s Mazor™ robotic guidance system combines surgical navigation with operative planning so you can perform spinal surgery more efficiently.
“Medtronic is honored to receive the 2025 Outstanding Company Award. This recognition highlights how the groundbreaking innovation led by our global teams fulfills our Mission and positively impacts patient lives around the world – something we’ve done for 75 years and will continue to do as we shape the future of surgery. For us, it’s about more than just technology; it’s about empowering providers and creating better patient experiences through comprehensive surgical robotic platforms – like Mazor™, Hugo™ RAS and Touch Surgery™ ecosystem – where robotic tools enable a doctor’s hands, advanced imaging and navigation augment their eyes, and a digital and AI-enabled ecosystem strengthen their knowledge and intuition. “
Bill Peine, Founder & Leader, Robotic Technology Development Center, Medtronic
Category: Groundbreaking Technology
Winner: MicroPort® MedBot™ – Toumai® Robot
The Toumai® Endoscopic Surgical Robot by MicroPort® MedBot™ is a minimally invasive surgical robotic system designed to enhance precision and reduce invasiveness in minimally invasive procedures. It features a four-arm robotic unit with seven degrees of freedom, tremor filtration, and wristed instruments, providing surgeons with superior dexterity and stability. The system includes an ergonomic surgeon console, precision patient cart, and high resolution imaging vehicle.
“MicroPort® MedBot™ is honored that the Toumai® Surgical Robot has received the 2025 “Breakthrough Technology” Award. This recognition is not only a testament to our technological strength but also an affirmation of our long-standing commitment to pioneering innovation. Toumai®’s groundbreaking advances in remote surgical technology are helping to usher the world into a new era of “telesurgery.” What we are breaking through is more than just technology — we are bridging geographic divides, overcoming resource gaps, and addressing global disparities in access to care.
At MicroPort® MedBot™, we firmly believe that truly valuable technology should not be created for the few but should bring hope and possibilities to every patient in need. From China to the world, we strive to connect lives through technology, reshape equity through innovation, and work hand in hand with global partners to build a smarter, more accessible, and more equitable surgical robotics ecosystem.“
President He Chao of MicroPort® Robotics
Category: Outstanding Healthcare Provider
Winner: Cromwell Hospital
Cromwell Hospital in London is a pioneer in robotic-assisted surgery, investing in advanced systems such as the da Vinci Xi and da Vinci SP to perform minimally invasive procedures across various specialties, including urology, gynaecology, colorectal, and hepatopancreatobiliary (HPB).
“We are proud to have been acknowledged by the Surgical Robotics Technology Awards and win Outstanding Healthcare Provider. This award shows our commitment to innovation and making sure our patients have access to the very best care, equipment, and treatment.”
Philip Luce, CEO, Diagnostic and Secondary Care London
“This year’s winners are not only advancing the surgical robotics field but laying the foundation for a future where precision, safety, and intelligence converge in the operating room. At QNX, we are honored to support the innovators who are transforming what’s possible in patient care.”
Mattias Eriksson, President, QNX
“Congratulations to this year’s winners and finalists, each playing an important role in pushing the boundaries of surgical robotics and shaping the future of the industry. A big thank you to our partner, QNX, and to the thousands who voted. The passion and innovation within the surgical robotics community is unmatched, and we’re honoured to be part of it.”
Josef de Pfeiffer, Founder of Surgical Robotics Technology
For more information on the Surgical Robotics Industry Awards and to stay informed of our plans for 2026, be sure to follow our LinkedIn Channel.
- The Medtronic Hugo™ RAS system is commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability. In the EU, the Hugo™ RAS system is CE marked. In the U.S., the Hugo™ system is an investigational device not for sale.
